Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027651 (
tumor
)
685,946
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The need for constant vigilance in the follow-up care of patients with
transitional cell carcinoma
is illustrated by the case reports of 12 patients whose tumors recurred after
tumor
-free periods of eleven years and longer. Emphasis is placed on monitoring, which includes pyelographic study, cytologic study, and cystoscopic examinations for as long as the patient survives.
...
PMID:Urothelial neoplasia: what constitutes adequate follow-up? 62 86
Adenosine deaminase is an important enzyme in purine metabolism, and patients with abnormal lymphocyte and erythrocyte adenosine deaminase levels have been shown to have impaired immune competence. Since immune factors have been shown to be important in patients with transitional cell carcinoma of the bladder we studied adenosine deaminase activity in the hemic cells of 48 patients with this
tumor
. Lymphocyte adenosine deaminase levels were elevated in patients with
transitional cell carcinoma
and correlated with stage, activity, clinical course and
tumor
resection but not with
tumor
grade. Erythrocyte adenosine deaminase levels also were elevated in patients with
transitional cell carcinoma
but did not correlate with other disease parameters. Lymphocyte adenosine deaminase activity in patients with
transitional cell carcinoma
may be a sensitive indicator of disease activity and further studies may provide insight into the host-
tumor
relationship at the enzyme level.
...
PMID:Adenosine deaminase activity in patients with carcinoma of the bladder. 64 89
In a review of cases of
neoplasia
in dogs seen at The Animal Medical Center during a 6-year period, 20 cases of primary urethral tumors were found. The majority of these cases were in older dogs (av abe, 10.4 years) and females (18/20). The most common clinical signs were hematuria and stranguria. Nineteen of the 20 tumors were diagnosed clinically, and the most consistent and useful diagnostic method was pneumocystography-cystography, with voiding urethrography. Of the 5
tumor
types (squamous cell carcinoma,
transitional cell carcinoma
, adenocarcinoma, hemangiosarcoma, and embryonic rhabdomyosarcoma), squamous cell carcinoma was the most common (12/20). Metastasis occurred in 6 of the 20 dogs. Because of metastasis to regional lymph nodes and diffuse extent of the
tumor
in the urethra in many of the dogs, a caudal abdominal approach for surgical excision is recommended if treatment is attempted.
...
PMID:Primary urethral tumors in dogs. 64 87
Seventy patients with
transitional cell carcinoma
of the kidney operated upon at Barnes Hospital during the last 25 years are reviewed. The relationship of the pathologic stage, grade, findings on excretory urography and survival is studied. The stage and survival rates were predicted fairly accurately on the basis of the excretory urogram alone. Survival of patients was determined occasionally by the status of the associated bladder tumors more than by the renal cancer. Because of
tumor
multiplicity we recommend total nephroureterectomy as the treatment of choice. The role of radiation therapy is considered.
...
PMID:Transitional cell carcinoma of the kidney 25-year experience. 66 Jul 26
A patient with known transitional cell carcinoma of the bladder and hypercalcemia was evaluated for urinary prostaglandin levels when no bone metastases or elevated parathormone levels could be demonstrated. Urinary levels of prostaglandin E metabolite were assessed in relation to serum and urinary calcium levels during treatment. The serum calcium levels decreased from the 13.0 mg. per cent range whenever the rpimary
tumor
was manipulated (transurethral resection) or when other treatments directed at the
tumor
were used (radiation therapy and chemotherapy). Serum and urinary calcium levels, and urinary prostaglandin E metabolite decreased when 3 gm. aspirin were given daily. These data suggest that the somewhat unusual hypercalcemia in our patient was caused by a prostaglandin-secreting
transitional cell carcinoma
. Prostaglandin-secreting tumors are reviewed herein.
...
PMID:Prostaglandin-mediated hypercalcemia in transitional cell carcinoma of the bladder. 66 Jul 46
The leukocyte adherence inhibition test was used to evaluate the cellular immune status of 16 patients with a histological diagnosis of transitional cell carcinoma of the bladder. The reactivity of the leukocytes was measured against extracts of
transitional cell carcinoma
as well as renal cell carcinoma. The leukocytes of age and sex-matched control subjects, as well as patients with urinary tract infection, also were studied. The leukocytes of patients with
transitional cell carcinoma
were more reactive to extracts of
transitional cell carcinoma
. These results suggest that a response to
tumor
-associated antigens is present in
transitional cell carcinoma
patients.
...
PMID:Cellular immunity in bladder cancer patients. 66 Jul 59
The carcinogenic activity of orally administered N-bis(2-hydroxypropyl)-nitrosamine (DHPN) in male Wistar rats was evaluated with respect to its dose. DHPN was administered at two doses, 100 ppm and 500 ppm, in the drinking water to rats for 25 to 52 weeks.
Tumors
developed in the lung, liver, and thyroid of rats receiving 100 ppm DHPN and in the lung, liver thyroid, esophagus, kidney, and urinary bladder of rats receiving 500 ppm DHPN. The principal target organ was the lung in rats receiving either 100 or 500 ppm DHPN, indicating that the carcinogenic action of these doses of DHPN was similar to that of higher doses previously reported. Histologically, the tumors were adenoma, adenocarcinoma, squamous cell carcinoma, and combined carcinoma of the lung, hepatocellular carcinoma and hemangioma of the liver, adenoma and adenocarcinoma of the thyroid, squamous cell papilloma and carcinoma of the esophagus, renal cell and transitional carcinoma of the kidney, and
transitional cell carcinoma
of the urinary bladder. No pancreatic tumors were observed.
...
PMID:Effect of dose on the carcinogenic activity of orally administered N-bis(2-hydroxypropyl)nitrosamine in rats. 71 Aug 6
We obtained 246 cold cup biopsies from pre-selected sites of apparently non-
tumor
-bearing bladder urothelium from 82 patients who presented with bladder cancer for the first time. Of 75 patients with
transitional cell carcinoma
32 (43 per cent) suffered coincidental urothelial abnormalities, the most common being atypia. Significant abnormalities occurred more commonly (77 per cent) in association with high grade tumors than with low grade tumors (15 per cent).
...
PMID:Biopsy of apparently normal urothelium in patients with bladder carcinoma. 71 98
Twenty-four patients with invasive
transitional cell carcinoma
of the urinary bladder, recurrent after radiotherapy, were treated by intra-arterial infusion of
tumor
-immune pig lymph node cells. In 11 patients there was a remission of the disease process, and 3 patients remain alive and free of disease in excess of one year after treatment.
...
PMID:Transfer of adoptive immunity by intra-arterial injection of tumor-immune pig lymph node cells: treatment of recurrent urinary bladder carcinoma after radical radiotherapy. 71 64
Six female beagle dogs were given a daily dose of 100 mg MOCA, by capsule, 3 days per week for the first 6 weeks and then 5 days per week continuously for periods up to 9.0 years. The dose varied from 8 to 15 mg/kg body weight/day among the dogs. Six female beagle dogs were kept as untreated controls. The test was terminated after 9.0 years of treatment. The average plasma glutamic-pyruvic transaminase activity of the dogs fed MOCA was higher than that of the controls during the first and last two years on test. During the eighth and ninth years the urine sediment from MOCA dogs contained excessive numbers of erythrocytes, leukocytes, and epithelial cells. Some epithelial cells contained abnormalities that suggested
neoplasia
in the genitourinary tract. One MOCA dog, sacrificed after 8.3 years on test was found to have a papillary
transitional cell carcinoma
of the urinary bladder. Of four MOCA dogs sacrificed after 9.0 years on test, three were found to have papillary transitional cell carcinomas of the urinary bladder and one had a combined
transitional cell carcinoma
and adenocarcinoma of the urethra. The urethral
tumor
had metastasized to the liver, but the papillary transitional cell carcinomas found in the other four dogs did not invade the muscle layers of the bladder wall and did not metastasize. Since no urinary bladder tumors were found in the six control dogs, MOCA was considered to be carcinogenic for the urinary bladder of dogs under the conditions employed (p less than 0.025, Fisher's Exact Test, one tail). Three of five MOCA dogs contained hyperplastic nodules in the liver with no such nodules in six control dogs (p greater than 0.05, Fisher's Exact Test, one tail). This was considered to be suggestive of an effect of MOCA treatment.
...
PMID:Urinary bladder tumors in dogs from 4,4'-methylene-bis (2-chloroaniline) (MOCA). 72 85
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>